Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A injections for post-stroke stiff knee gait
NL-OMON29171Not yet recruiting
- Sponsor
- Roessingh Research & Development
- Start
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in stroke (2 arms), sponsored by Roessingh Research & Development. Primary endpoints: Knee flexion during swing phase, Electromyogram measurements and 10 more. Planned start Mar 2013; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
stroke
Beyond the preview
Go deeper on NL-OMON29171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29171.